Table 2.

Descriptive and inferential statistics for clinical outcome measures.

Outcome variables	Mann-Whitney test between-group differences
	T1 vs. T0 P value (Effect size)	T2 vs. T0 P value (Effect size)
PRIMARY OUTCOME MEASURE
Gait speed (cm/s)	0.644 (0.10)	0.895 (0.02)
BBS (0–56)	0.547 (0.13)	0.091 (0.28)
SECONDARY OUTCOME MEASURES
ABC scale (0–100)	0.741 (0.09)	0.692 (0.08)
SOT—S. surface (0–150) EO	0.197 (−0.34)	0.075 (−0.37)
EC	0.947 (−0.13)	0.210 (−0.27)
Dome	0.187 (0.29)	0.553 (0.15)
SOT—C. surface (0–150) EO	0.843 (−0.05)	0.553 (0.01)
EC	0.644 (−0.12)	0.291 (−0.30)
Dome	0.129 (−0.31)	0.048 (−0.32)*
SA EO condition
Sway area (mm2)	0.817 (−0.20)	0.553 (−0.10)
Length CoP (mm)	0.468 (−0.05)	0.895 (−0.10)
SA EC condition
Sway area (mm2)	0.210 (0.20)	0.598 (0.10)
Length CoP (mm)	0.767 (0.20)	0.895 (−0.03)
Gait analysis
Cadence (step/min)	0.322 (−0.22)	0.339 (−0.25)
SL (cm)	0.235 (−0.11)	0.644 (0.02)
SS time (% of cycle)	0.742 (0.15)	0.974 (−0.15)
DS time (% of cycle)	0.065 (0.41)	0.166 (0.15)
FSS (1–7)	0.276 (0.18)	0.391 (0.08)
MSQOL-54 PHC (0–100)	0.261 (−0.27)	0.869 (−0.06)
MSQOL-54 MHC (0–100)	0.667 (−0.15)	0.235 (0.07)

Before, pre-treatment; After, post-treatment; SD, standard deviation; P Value, p value; BBS, berg balance scale (higher score = better performance); ABC scale, activities balance confidence scale (higher score = better performance); SOT, sensory organization balance test; EO, eyes-open condition; EC, eyes-closed condition; S, stable; C, compliant; SA, stabilometric assessment; Length CoP, length of CoP trajectory; FSS, fatigue severity scale (higher score = worse performance); SL, step length; SS, SINGLE support time; DS, double support time; MSQOL-54 PHC, multiple sclerosis quality of Life-54 physical health (higher score = better performance); MSQOL-54 MHC, multiple sclerosis quality of Life-54 mental health;

^*Statistically significant; p value significant if <0.05.